Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             78 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 3.502 A comprehensive model of health-related quality of life in Parkinson's disease: Challenges for patient management Visser, M.
2007
13 Supplement 3 p. S187-S188
2 p.
artikel
2 1.278 Adult onset dystonic tremor as differential diagnosis for Parkinson's disease: Detailed clinical description of 20 patients emphasizing non-motor symptoms including olfactory function Schwingenschuh, P.
2007
13 Supplement 3 p. S70-S71
2 p.
artikel
3 Allied health care interventions and complementary therapies in Parkinson's disease Nijkrake, M.J.
2007
13 Supplement 3 p. S488-S494
7 p.
artikel
4 2.447 AMPA antagonists attenuate L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat model of Parkinson's disease Kobylecki, C.
2007
13 Supplement 3 p. S140-
1 p.
artikel
5 2.110 Association of PARKIN gene polymorphisms with Parkinson's disease in the Russian population Demchuk, N.
2007
13 Supplement 3 p. S94-
1 p.
artikel
6 3.314 Associations between the use of cueing specific guidelines and gait in Parkinson's disease: The RESCUE trial Lim, I.
2007
13 Supplement 3 p. S179-
1 p.
artikel
7 2.306 A yeast-based screening system for mouse brain proteins that modify the toxicity of alpha-synuclein de Graeve, S.
2007
13 Supplement 3 p. S123-
1 p.
artikel
8 2.450 Beneficial effects of the new multitargeting molecules BN82451 and BN83026 on tardive dyskinesia induced by haloperidol in rats Auguet, M.
2007
13 Supplement 3 p. S141-
1 p.
artikel
9 1.292 Beneficial impact of pramipexole on social functioning in patients with restless legs syndrome Zesiewicz, T.
2007
13 Supplement 3 p. S74-
1 p.
artikel
10 3.301 Causes of falls in retrospective and prospective study in Parkinson's disease patients Rudzińska, M.
2007
13 Supplement 3 p. S175-
1 p.
artikel
11 3.103 Change of the midbrain size in normal aging and progressive supranuclear palsy: An MRI study Sung, Y.-H.
2007
13 Supplement 3 p. S153-
1 p.
artikel
12 1.309 Clinical and molecular studies of patients screened for Huntington's disease in a movement disorders clinic from Brazil Riccioppo, G.
2007
13 Supplement 3 p. S79-
1 p.
artikel
13 Contents 2007
13 Supplement 3 p. vii-
1 p.
artikel
14 Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease Pfeiffer, Ronald F.
2007
13 Supplement 3 p. 93-100
8 p.
artikel
15 2.222 Continuous dopaminergic stimulation in advanced PD. Switching from apomorphine to duodopa: Which treatment is better? Tamburin, S.
2007
13 Supplement 3 p. S103-
1 p.
artikel
16 3.412 Current practice in occupational therapy for patients with Parkinson's disease Sturkenboom, I.
2007
13 Supplement 3 p. S183-
1 p.
artikel
17 2.205 Design of the A to Z (Agonists to Zelapar) trial: Adding orally disintegrating selegiline to dopamine agonists in patients with Parkinson's disease experiencing complications Isaacson, S.
2007
13 Supplement 3 p. S98-
1 p.
artikel
18 2.266 Detrimental effect of levodopa on sleep-dependent consolidation of an implicit learning task Wailke, S.
2007
13 Supplement 3 p. S116-
1 p.
artikel
19 Developing a PD Service Baker, Mary G.
2007
13 Supplement 3 p. S498-S500
3 p.
artikel
20 1.166 Diagnosis of personality structure and cognition in patients with Parkinson's disease Schiavella, M.
2007
13 Supplement 3 p. S50-S51
2 p.
artikel
21 3.014 Diagnostic value of meta-iodobenzyl-guanidine myocardial scintigraphy in the differential diagnosis of senile dementia of the Alzheimer type and Diffuse Lewy Body Disease Versijpt, J.
2007
13 Supplement 3 p. S149-
1 p.
artikel
22 Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: A prospective 12-month paired TMS study Bareš, Martin
2007
13 Supplement 3 p. 489-494
6 p.
artikel
23 2.321 Do chronic non-specific brain insults predispose to incidental Lewy Body Disease? An exploratory study Frigerio, R.
2007
13 Supplement 3 p. S127-
1 p.
artikel
24 2.239 Dose strength equivalence and dose proportionality demonstrated with ropinirole 24-hour prolonged release Vearer, D.
2007
13 Supplement 3 p. S108-
1 p.
artikel
25 1.152 Dribbling of saliva in Parkinson's disease: Clinical correlations Lewis, H.
2007
13 Supplement 3 p. S47-
1 p.
artikel
26 1.213 Dysarthria in progressive supranuclear palsy Mallien, G.
2007
13 Supplement 3 p. S63-S64
2 p.
artikel
27 Editorial Board 2007
13 Supplement 3 p. IFC-
1 p.
artikel
28 3.235 Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson's disease Eusebio, A.
2007
13 Supplement 3 p. S171-
1 p.
artikel
29 3.201 Enhanced survival and function of neural stem cells derived dopaminergic neurons under surveillance of olfactory ensheathing cells in parkinsonian rats Shukla, S.
2007
13 Supplement 3 p. S161-
1 p.
artikel
30 3.230 Exercise performance in Parkinson's disease before and 3 months after DBS-STN operation Jørgensen, H.U.
2007
13 Supplement 3 p. S170-
1 p.
artikel
31 3.304 Gait disorders and increase of the step variability for cerebrovascular diseases: Diagnostics using the computer hardware–software complex “Dorozhka” Pokhabov, D.
2007
13 Supplement 3 p. S176-
1 p.
artikel
32 Impact of physical therapy for Parkinson's disease: A critical review of the literature Kwakkel, G.
2007
13 Supplement 3 p. S478-S487
10 p.
artikel
33 1.199 Increased reaction time predicts deficit of explicit visual learning in the early stages of Parkinson's disease Ghilardi, M.F.
2007
13 Supplement 3 p. S59-S60
2 p.
artikel
34 2.IS.2.1 Dopamine agonists in controlling motor symptoms – clinical relevance of trials Emre, M.
2007
13 Supplement 3 p. S145-
1 p.
artikel
35 3.IS.4.3 How to start in your clinic? Implementation and practical guidelines Munneke, M.
2007
13 Supplement 3 p. S191-
1 p.
artikel
36 1.020 Is psychopathology part of the phenotypic spectrum of Myoclonus–Dystonia? A study of a large Dutch M-D family Foncke, E.
2007
13 Supplement 3 p. S32-
1 p.
artikel
37 2.252 Lisuride long term s.c. infusion in advanced Parkinson's disease patients unresponsive to oral treatments Stocchi, F.
2007
13 Supplement 3 p. S112-
1 p.
artikel
38 2.402 Low-dose pesticide exposure and early stages of Parkinsonism in a rat model Vanbesien-Mailliot, C.
2007
13 Supplement 3 p. S128-
1 p.
artikel
39 2.426 Mechanism of degradation of Bad protein by the green tea polyphenol (−)-epigallocatechin-3-gallate: Implication for neuroprotection Kalfon, L.
2007
13 Supplement 3 p. S134-
1 p.
artikel
40 Myoclonus Caviness, John N.
2007
13 Supplement 3 p. S375-S384
10 p.
artikel
41 NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation Qian, Li
2007
13 Supplement 3 p. S316-S320
5 p.
artikel
42 Nitrous oxide promotes hyperhomocysteinemia in levodopa treated rats Henninger, Nils
2007
13 Supplement 3 p. 524-527
4 p.
artikel
43 1.126 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): Results form the international PD non-motor symptoms scale study Naidu, Y.
2007
13 Supplement 3 p. S40-
1 p.
artikel
44 Olfaction in Parkinson's Disease Doty, Richard L.
2007
13 Supplement 3 p. S225-S228
4 p.
artikel
45 1.112 Olfactory dysfunction in Parkinson's disease: Is extended testing useful to discriminate between patients and controls? Boesveldt, S.
2007
13 Supplement 3 p. S37-
1 p.
artikel
46 2.002 PD: Autonomic dysfunction Reichmann, H.
2007
13 Supplement 3 p. S87-
1 p.
artikel
47 3.426 PDCreativity.org: A web-based resource for improving the quality of life of people with Parkinson's disease Stone, S.
2007
13 Supplement 3 p. S186-S187
2 p.
artikel
48 1.001 PD: Motor and non-motor fluctuations van Laar, T.
2007
13 Supplement 3 p. S29-
1 p.
artikel
49 Peripheral trauma and movement disorders van Hilten, Jacobus J.
2007
13 Supplement 3 p. S395-S399
5 p.
artikel
50 2.269 Plasma homocysteine levels in idiopathic Parkinson's disease: Role of idiopathic Parkinson's disease and levodopa treatment Ha, S.-W.
2007
13 Supplement 3 p. S116-
1 p.
artikel
51 2.451 Possible antioxidant mechanisms of cyclooxygenase inhibitors against 3-nitropropionic acid induced neurotoxicity in rats Kumar, A.
2007
13 Supplement 3 p. S141-
1 p.
artikel
52 2.230 Pramipexole monotherapy in the treatment of early Parkinson's disease: Results of a 3 year follow up of a randomized controlled study Oztekin, N.
2007
13 Supplement 3 p. S106-
1 p.
artikel
53 Presynaptic plasticity: modulation of secretion, co-transmission and neurodegeneration Verhage, Matthijs
2007
13 Supplement 3 p. S250-
1 p.
artikel
54 2.416 Proteomic analysis of ventral midbrain in MPTP-treated normal and L1cam transgenic mice Diedrich, M.
2007
13 Supplement 3 p. S131-S132
2 p.
artikel
55 3.117 Raclopride PET in the differential diagnosis of multiple system atrophy and Parkinson's disease using discriminant analysis Clerinx, K.
2007
13 Supplement 3 p. S157-S158
2 p.
artikel
56 Recognition memory for unfamiliar faces in Parkinson's disease: Behavioral and electrophysiologic measures Kida, Yasunobu
2007
13 Supplement 3 p. 157-164
8 p.
artikel
57 2.021 Regulation of the iron-responsive proteins amyloid precursor protein and alpha-synuclein by green tea polyphenol (−)-epigallocatechin-3-gallate Reznichenko, L.
2007
13 Supplement 3 p. S91-
1 p.
artikel
58 2.317 Regulation of the iron-responsive proteins amyloid precursor protein and alpha-synuclein by green tea polyphenol (−)-epigallocatechin-3-gallate Reznichenko, L.
2007
13 Supplement 3 p. S126-
1 p.
artikel
59 1.326 Reversible general paresis and hippocampus hyperintensities after intensive neurosyphilis treatment: A case report Fabiani, G.
2007
13 Supplement 3 p. S83-
1 p.
artikel
60 1.295 Ropinirole CR significantly improves quality of life in patients with restless legs syndrome Bogan, R.
2007
13 Supplement 3 p. S75-
1 p.
artikel
61 2.236 Ropinirole used as an adjunct to levodopa is effective on motor function in Parkinson's disease Oztekin, N.
2007
13 Supplement 3 p. S107-
1 p.
artikel
62 1.197 Sequence learning and the basal ganglia Ghilardi, M.F.
2007
13 Supplement 3 p. S59-
1 p.
artikel
63 1.323 Siblings of SCA type 2 with heterogenous neurodegenerative disorders Yabe, H.
2007
13 Supplement 3 p. S82-S83
2 p.
artikel
64 1.169 Sleep disorders and depression among black Parkinson's disease patients: A study of 37 patients in University of Maiduguri Teaching Hospital Nyandaiti, Y.
2007
13 Supplement 3 p. S51-
1 p.
artikel
65 1.139 Sleep disturbance and daytime sleepiness in Flemish persons with Parkinson's disease Kerckhofs, E.
2007
13 Supplement 3 p. S43-
1 p.
artikel
66 1.136 Sleep-related problems in patients with Parkinson's disease Lee, H.-W.
2007
13 Supplement 3 p. S42-S43
2 p.
artikel
67 1.183 SPAARS approach: A new theoretical framework for self-injurious behavior Khetrapal, N.
2007
13 Supplement 3 p. S55-
1 p.
artikel
68 Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy Armstrong, Richard A.
2007
13 Supplement 3 p. 50-54
5 p.
artikel
69 SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease Ashkan, Keyoumars
2007
13 Supplement 3 p. 266-275
10 p.
artikel
70 Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: A retrospective evaluation of Japanese patients with Parkinson's disease Yamada, Kazumichi
2007
13 Supplement 3 p. 101-107
7 p.
artikel
71 3.218 Surgical treatment improving quality of life in Parkinson's disease Singh, A.
2007
13 Supplement 3 p. S166-
1 p.
artikel
72 The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease Kandinov, Boris
2007
13 Supplement 3 p. 243-245
3 p.
artikel
73 2.283 The frequency of cardiac valve regurgitation in Japanese patients with Parkinson's disease using pergolide Kimura, K.
2007
13 Supplement 3 p. S120-
1 p.
artikel
74 2.433 The possibility of kynurenine metabolites binding to ionotropic glutamate receptors and to calmodulin: data on molecular modeling and Drosophila kynurenic mutants Zhuravlev, A.
2007
13 Supplement 3 p. S136-
1 p.
artikel
75 Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's Disease and dystonia Rothwell, John
2007
13 Supplement 3 p. S417-S420
4 p.
artikel
76 What you always wanted to know about … Early Markers in PD W. Berendse, Henk
2007
13 Supplement 3 p. S92-
1 p.
artikel
77 What you always wanted to know about … Medical history Goldman, Jennifer
2007
13 Supplement 3 p. S152-
1 p.
artikel
78 3.204 Zuckerkandl's organ improves long-term survival and function of neural stem cells derived dopaminergic neurons in Parkinsonian rats Chaturvedi, R.K.
2007
13 Supplement 3 p. S162-S163
2 p.
artikel
                             78 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland